home / stock / sppi / sppi news


SPPI News and Press, Spectrum Pharmaceuticals Inc. From 11/04/20

Stock Information

Company Name: Spectrum Pharmaceuticals Inc.
Stock Symbol: SPPI
Market: NASDAQ
Website: sppirx.com

Menu

SPPI SPPI Quote SPPI Short SPPI News SPPI Articles SPPI Message Board
Get SPPI Alerts

News, Short Squeeze, Breakout and More Instantly...

SPPI - Spectrum Pharmaceuticals EPS misses by $0.02

Spectrum Pharmaceuticals (SPPI): Q3 Non-GAAP EPS of -$0.27; GAAP EPS of -$0.37 misses by $0.02.The company ended the quarter with cash, cash equivalents, and marketable securities of $198.3 million.Press Release For further details see: Spectrum Pharmaceuticals EPS misses by $0.02

SPPI - Spectrum Pharmaceuticals Reports Third Quarter 2020 Financial Results and Corporate Update

FDA deferred action on the BLA for ROLONTIS ® (eflapegrastim) due to inability to conduct inspection of the manufacturing facility citing COVID-19 related travel restrictions Pre-NDA meeting with FDA is scheduled for poziotinib in NSCLC HER2 exon-20 insertion muta...

SPPI - Spectrum Pharmaceuticals to Report Third Quarter 2020 Financial Results and Provide Corporate Update

Spectrum Pharmaceuticals (NasdaqGS: SPPI) a biopharmaceutical company focused on novel and targeted oncology therapies, today announced it will host a conference call to discuss the third quarter 2020 financial results and provide a corporate update on Wednesday, November 4, 2020 at 4:3...

SPPI - FDA delays action on Spectrum's Relontis application pending on-site inspection

Spectrum Pharmaceuticals ([[SPPI]] +2.2%) reports that the FDA will delay its decision on its marketing application for Rolontis (eflapegrastim) for the potential treatment of neutropenia in chemo patients until it conducts an on-site inspection of the Hanmi Bioplant in South Korea. The agenc...

SPPI - Spectrum Pharmaceuticals Announces that the FDA is Deferring its Action on the BLA for ROLONTIS® (eflapegrastim)

Agency cites inability to conduct inspection of the drug substance manufacturing facility due to COVID-19 related travel restrictions Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that...

SPPI - Foghorn Therapeutics Files Terms For $120 Million IPO

Foghorn Therapeutics has filed to raise $120 million in a U.S. IPO. The firm is developing treatments for ocular cancer and other cancers. FHTX is still at a preclinical stage of development, so the IPO may be more suited to long-term hold institutional investors. For furthe...

SPPI - 5 Penny Stocks To Watch Now With Recent & Upcoming Biotech Events

Penny Stocks To Watch This Week If you’re wondering which penny stocks to watch this week , you’ve got a broad array of choices. Are you going to focus on general momentum stocks or will sectors take your focus? Whichever the case, just make sure to have a plan in ...

SPPI - Seeking Alpha Catalyst Watch

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...

SPPI - 4 Penny Stocks To Buy According To Analysts; 1 With A 189% Target

Analysts Have High Hopes For These Penny Stocks When it comes to penny stocks , they’re a dime a dozen. There are thousands of stocks under $5 to choose from. The biggest thing traders focus on is how to make money with penny stocks quickly . That’s one of the ...

SPPI - Top Biotech Penny Stocks To Watch For October 2020

Should These Biotech Penny Stocks Be On Your List Right Now? Biotech penny stocks are some of the most sought after in the stock market today. It isn’t because they’re leading the market. For the most part, investors look to these penny stocks for their future potentia...

Previous 10 Next 10